beta-lactam

DRUG3 trials

Sponsors

Hoffmann-La Roche, Menzies School of Health Research

Conditions

Methicillin-Resistant Staphylococcus AureusPneumonia, BacterialSoft Tissue Infections

Phase 2

A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

CompletedNCT00111644

Hoffmann-La RochePneumonia, Bacterial

Start: 2005-03-31End: 2007-01-31Updated: 2016-11-02

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

CompletedNCT00303589

Hoffmann-La RocheSoft Tissue Infections

Start: 2005-12-31End: 2007-10-31Updated: 2016-11-02

Phase 3

Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection

TerminatedNCT02365493

Menzies School of Health ResearchMethicillin-Resistant Staphylococcus Aureus

Start: 2015-08-26End: 2018-10-24Updated: 2018-12-19

Related Papers

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

JAMA2020-02-11260 citations

CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial

Trials2016-03-3174 citations